Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications
- PMID: 34960023
- PMCID: PMC8708207
- DOI: 10.3390/nu13124471
Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications
Abstract
Background: Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer (MIBC). Neoadjuvant chemotherapy (NAC) is associated with improved patient survival. The impact of NAC on nutritional status is understudied, while the association between malnutrition and poor surgical outcomes is well known. This study aims to examine the association between NAC, nutritional status impairment, and post-operative morbidity.
Materials and methods: We included MIBC patients who underwent RC and received NAC from multiple academic centers in Israel. Cross-sectional imaging was used to measure the psoas muscle area and normalized it by height (smooth muscle index, SMI). Pre- and post-NAC SMI difference was calculated (represents nutritional status change). The primary outcomes were post-RC ileus, infection, and a composite outcome of any complication. Logistic regression models were fit to identify independent predictors of the outcomes.
Results: Ninety-one patients were included in the study. The median SMI change was -0.71 (-1.58, -0.06) cm2/m2. SMI decline was significantly higher in patients with post-RC complications (-18 vs. -203, p < 0.001). SMI change was an independent predictor of all complications, ileus, infection, and other complications. The accuracy of SMI change for predicting all complications, ileus, infection, and other complications was 0.85, 0.87, 0.75, and 0.86, respectively.
Conclusions: NAC-related nutritional deterioration is associated with increased risk of complications after RC. Our results hint towards the need for nutritional intervention during NAC prior to RC.
Keywords: complication; nutrition; radical cystectomy; sarcopenia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy.Minerva Urol Nephrol. 2021 Apr;73(2):215-224. doi: 10.23736/S2724-6051.20.03616-4. Epub 2020 Feb 19. Minerva Urol Nephrol. 2021. PMID: 32083413
-
Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.BJU Int. 2014 Aug;114(2):221-8. doi: 10.1111/bju.12585. Epub 2014 Mar 14. BJU Int. 2014. PMID: 24274722 Free PMC article.
-
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2. Eur Urol. 2019. PMID: 30290956 Free PMC article.
-
Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review.Bladder Cancer. 2021;7(4):449-461. doi: 10.3233/blc-200428. Epub 2021 Dec 13. Bladder Cancer. 2021. PMID: 34993293 Free PMC article.
-
The Handling and Sampling of Radical Cystectomy Specimens: A Standardized Approach for Pathological Evaluation.Methods Protoc. 2025 Apr 5;8(2):35. doi: 10.3390/mps8020035. Methods Protoc. 2025. PMID: 40278509 Free PMC article. Review.
Cited by
-
Malnutrition Prevalence and Its Implications on Surgical and Oncological Outcomes in Advanced Ovarian Cancer Patients: A Comprehensive Analysis.Obstet Gynecol Int. 2025 May 10;2025:2918759. doi: 10.1155/ogi/2918759. eCollection 2025. Obstet Gynecol Int. 2025. PMID: 40384994 Free PMC article.
-
Immunonutrition in Radical Cystectomy: State of the Art and Perspectives.Cancers (Basel). 2023 Jul 24;15(14):3747. doi: 10.3390/cancers15143747. Cancers (Basel). 2023. PMID: 37509408 Free PMC article. Review.
-
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments.Front Oncol. 2022 Jul 22;12:912699. doi: 10.3389/fonc.2022.912699. eCollection 2022. Front Oncol. 2022. PMID: 35936721 Free PMC article. Review.
-
Sarcopenia in Urinary Bladder Cancer: Definition, Prevalence and Prognostic Value in Survival.Maedica (Bucur). 2022 Jun;17(2):427-435. doi: 10.26574/maedica.2022.17.2.427. Maedica (Bucur). 2022. PMID: 36032591 Free PMC article.
-
Textbook oncological outcome of locally advanced gastric cancer patients with preoperative sarcopenia: a multicenter clinical study.Surg Endosc. 2025 Jan;39(1):356-367. doi: 10.1007/s00464-024-11397-3. Epub 2024 Nov 15. Surg Endosc. 2025. PMID: 39548007
References
-
- Witjes J.A., Compérat E., Cowan N.C., De Santis M., Gakis G., James N., Lebrét T., Sherif A., van der Heijden A.G., Ribal M.J. Muscle-invasive and metastatic bladder cancer. Eur. Urol. Guidel. 2015;71:462–475. - PubMed
-
- Caillet P., Liuu E., Simon A.R., Bonnefoy M., Guerin O., Berrut G., Lesourd B., Jeandel C., Ferry M., Rolland Y., et al. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin. Nutr. 2017;36:1473–1482. doi: 10.1016/j.clnu.2016.12.003. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical